Head over to our on-demand library to view sessions from VB Transform 2023. Register Here
Insilico Medicine, a clinical-stage AI drug-discovery company, announced a groundbreaking medical milestone: It successfully predicted Phase II to Phase III clinical trial outcomes using its proprietary generative transformer-based AI tool, inClinico.
The clinical stage accounts for approximately 90% of drug-development failures attributed to issues such as lack of efficacy, safety concerns…
